Hepatobiliary Surg Nutr. 2015 Dec;4(6):379-90. doi: 10.3978/j.issn.2304-3881.2015.06.06.
Laparoscopic liver resection for posterosuperior and anterolateral lesions-a comparison experience in an Asian centre.
Hepatobiliary surgery and nutrition
Jin Yao Teo, Juinn Huar Kam, Chung Yip Chan, Brian K P Goh, Jen-San Wong, Victor T W Lee, Peng Chung Cheow, Pierce K H Chow, London L P J Ooi, Alexander Y F Chung, Ser Yee Lee
Affiliations
Affiliations
- 1 Department of Hepatopancreatobiliary and Transplantation Surgery, Singapore General Hospital, Singapore ; 2 Duke-NUS Graduate Medical School, Singapore ; 3 Division of Surgical Oncology, National Cancer Center Singapore, Singapore ; 4 Office of Clinical Sciences, Duke-NUS Graduate Medical School, Singapore.
PMID: 26734622
PMCID: PMC4689685 DOI: 10.3978/j.issn.2304-3881.2015.06.06
Abstract
BACKGROUND: Minimally invasive surgery has been one of the recent developments in liver surgery, laparoscopic liver resection (LLR) was initially performed for benign lesions at easily accessible locations. As the surgical techniques, technology and experience improved over the past decades, LLR surgery had evolved to tackle malignant lesions, major resections and even in difficult locations without compromising safety and principles of oncology. It was also shown to be beneficial in cirrhotic patients. We describe our initial experience with LLR in a population with significant proportion having cirrhosis, emphasising our approach for lesions in the posterosuperior (PS) segments of the liver (segments 1, 4a, 7, and 8).
METHODS: A review of patients undergoing LLR in single institution from 2006 to 2015 was performed from a prospective surgical database. Clinicopathological, operative and perioperative parameters were analyzed to compare outcomes in patients who underwent LLR for PS vs. anterolateral lesions (AL).
RESULTS: LLR was performed in consecutive 197 patients, with a mean age of 60 years. The indications for resection were hepatocellular carcinoma (HCC) (n=105; 53%), colorectal cancer liver metastasis (n=31; 16%), other malignancies (n=19; 10%) and benign lesions (n=42; 21%). A significant proportion had liver cirrhosis (25.9%). More females underwent surgery in the AL group and indications for surgery were similar between both groups. Major liver resection was performed more frequently for the PS group than for the AL group (P<0.001) and significantly more PS resections was performed in our latter experience (P=0.02). The mean operative time and the conversion rate were significantly greater in the PS group than in the AL group (P≤0.001 and 0.03, respectively). However, the estimated blood loss (EBL), rate of blood transfusion and mean postoperative stay were similar in the two groups (P=0.04, 0.88 and 0.92, respectively). The overall 90-day morbidity and mortality rate was 21.3% and 0.5% respectively, with no differences between the two groups. Surrogates of difficulty such as operative time, blood loss, conversion and outcomes e.g., morbidity and mortality, were similar in patients who underwent PS resections with or without cirrhosis.
CONCLUSIONS: LLR in selected patients is technically feasible and safe including cirrhotic patients with lesions in the PS segments.
Keywords: Laparoscopic liver resection (LLR); colorectal cancer liver metastasis; hepatocellular carcinoma (HCC); posterosuperior (PS) and anterolateral lesions (AL)
References
- J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):732-6 - PubMed
- Surg Endosc. 2007 Nov;21(11):2004-11 - PubMed
- Ann Surg. 2009 Nov;250(5):825-30 - PubMed
- Am J Surg. 2005 Feb;189(2):190-4 - PubMed
- HPB (Oxford). 2014 Oct;16(10):943-53 - PubMed
- J Hepatobiliary Pancreat Sci. 2014 Oct;21(10):745-53 - PubMed
- Ann Surg. 2009 Jul;250(1):103-11 - PubMed
- Surg Endosc. 2005 Jul;19(7):886-91 - PubMed
- Surg Endosc. 2015 Sep;29(9):2636-42 - PubMed
- Surg Endosc. 2008 Nov;22(11):2344-9 - PubMed
- Br J Surg. 2007 Jan;94(1):58-63 - PubMed
- Arch Surg. 2003 Nov;138(11):1198-206; discussion 1206 - PubMed
- Am J Surg. 2005 Apr;189(4):474-8 - PubMed
- Ann Surg. 2002 Jul;236(1):90-7 - PubMed
- Surg Endosc. 2003 Dec;17(12):1914-8 - PubMed
- Surg Endosc. 2011 Dec;25(12):3881-9 - PubMed
- Ann Surg. 2009 Nov;250(5):772-82 - PubMed
- Ann Surg. 2009 Jun;249(6):995-1002 - PubMed
- J Am Coll Surg. 2000 Jul;191(1):38-46 - PubMed
- Am J Surg. 2009 Aug;198(2):173-7 - PubMed
- HPB (Oxford). 2015 Apr;17(4):299-303 - PubMed
- Ann Surg. 2013 Mar;257(3):377-82 - PubMed
- Surgery. 2008 Jul;144(1):32-8 - PubMed
- J Laparoendosc Adv Surg Tech A. 2012 Jun;22(5):488-91 - PubMed
- HPB (Oxford). 2013 Nov;15(11):908-15 - PubMed
- J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):E65-8 - PubMed
- Ann Surg. 2009 Nov;250(5):856-60 - PubMed
- World J Surg. 2014 Dec;38(12):3169-74 - PubMed
- Ann Surg Oncol. 2013 Apr;20(4):1266 - PubMed
- Surg Endosc. 2010 Sep;24(9):2327-37 - PubMed
- Ann Surg. 2000 Dec;232(6):753-62 - PubMed
- Ann Surg. 2004 Aug;240(2):205-13 - PubMed
- Surgery. 2007 Feb;141(2):203-211 - PubMed
- World J Surg. 2015 May;39(5):1202-9 - PubMed
- Surg Endosc. 2014 Aug;28(8):2484-92 - PubMed
- Br J Surg. 2009 Sep;96(9):1041-8 - PubMed
- J Hepatobiliary Pancreat Surg. 2009;16(3):310-4 - PubMed
Publication Types